TAG:
cap
Dade Behring Primed To Become Public Firm
By Robert Michel | From the Volume IX No. 11 – August 5, 2002 Issue
CEO SUMMARY: Dade Behring is executing an ambitious plan to restructure its finances and become a public company. To reduce its debt burden, Dade’s three owners are giving up their stock. Banks and bondholders will swap a portion of their debt for shares of stock in Dade. Once the finan…
Specialty Laboratories’ New CEO Reveals How His Company Is Changing
By Robert Michel | From the Volume IX No. 11 – August 5, 2002 Issue
“You will see a more tightly focused Specialty Labs. We won’t try and do everything, rather we will do what is important for our customers.” —Douglas S. Harrington, M.D CEO SUMMARY: In recent months, several events roiled the market for hos…
Specialty Progresses With CA Lab Regulators
By Robert Michel | From the Volume IX No. 10 – July 15, 2002 Issue
CEO SUMMARY: Earlier this month California laboratory regulators found Specialty Laboratories, Inc. to be “in substantial compliance with California clinical laboratory law.” This is an important milestone in restoring the lab company to full compliance with both state and federal labor…
Two Major Hospital Systems First to Join Leapfrog Group
By Robert Michel | From the Volume IX No. 10 – July 15, 2002 Issue
EXPERTS CONSIDER THE DECISION of two major hospital systems to join the Leapfrog Group to be a significant boost to the group’s effort to improve patient safety. HCA, Inc. of Nashville, Tennessee and Promina Health System of Atlanta are the first …
United Kingdom Soon to Tackle Consolidation of Hospital Labs
By Robert Michel | From the Volume IX No. 10 – July 15, 2002 Issue
CEO SUMMARY: Consolidation and regionalization of hospital laboratory testing are not isolated phenomenons. Beginning in the late 1980s, individual provinces in Canada began to rationalize lab testing services by building core labs and consolidating lab services across multiple hospitals….
Military Labs Creating Global Lab Test Data Pool With LOINC
By Robert Michel | From the Volume IX No. 9 – June 24, 2002 Issue
CEO SUMMARY: It’s a laboratory regionalization project without precedent because of its worldwide scale. Within the Armed Forces, laboratorians are working to seamlessly integrate laboratory test data generated by laboratories within the Army, Navy, Air Force, and Veterans Administratio…
Myriad Genetics, LabCorp, Abbott Labs, OraSure,TheraSense
By Robert Michel | From the Volume IX No. 9 – June 24, 2002 Issue
DIRECT-TO-CONSUMER ADS FROM MYRIAD GENETICS TO START THIS FALL FOLLOWING THE EXAMPLE of the pharmaceutical industry in using direct-to consumer advertising to build drug sales, Myriad Genetics, Inc. is about to launch an advertising campaign for its predictive genetics tests…
Big Fight is Brewing Over Lab Test Reimbursement
By R. Lewis Dark | From the Volume IX No. 8 – June 3, 2002 Issue
BY NOW, MOST LAB EXECUTIVES AND PATHOLOGISTS AGREE that Medicare Part B fees and reimbursement guidelines for lab testing have just about become de facto national standards. That’s because private payers increasingly use Medicare as the basis for building their own pricing and reimbursement guideli…
CPI Lab Fee Adjustment Threatened by New Bill
By Robert Michel | From the Volume IX No. 8 – June 3, 2002 Issue
CEO SUMMARY: Once again, the laboratory testing industry has been singled out as a healthcare “whipping boy” by Congressional aides. In working to develop the next federal budget, legislators again propose to deny annual CPI price updates for laboratory tests. This won’t be anything…
Vaccine Shortage Is Result Of Economic Disincentives
By Robert Michel | From the Volume IX No. 8 – June 3, 2002 Issue
RECENT PUBLICITY about the nationwide shortage of vaccines makes it timely to remind laboratory executives and pathologists about the important role that economics plays in providing goods and services to the healthcare marketplace. After all, good management strategy must incorporate an accurate as…
CURRENT ISSUE

Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized